Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:43.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a Phase 2 study involving tislelizumab and fruquintinib, while adding new identifiers and collaborators related to advanced solid tumors.
    Difference
    17%
    Check dated 2025-04-16T10:27:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:09:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:14:47.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the results of a Phase 2 study on the efficacy and safety of tislelizumab in combination with fruquintinib for advanced cancers, with specific details on study design, participant criteria, and outcome measures now included. Additionally, the results reporting dates have been updated.
    Difference
    84%
    Check dated 2025-03-25T13:19:05.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice about heavy traffic affecting certain services and the absence of posted results, while adding a confirmation that results have been submitted.
    Difference
    2%
    Check dated 2025-03-03T22:31:43.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.